| Product |
CAS |
Molecular formula |
More |
| 1-{4-[(3-Methoxypiperidin-1-yl)methyl]phenyl}-n-methylmethanamine |
1211576-53-2 |
C15H24N2O |
More |
| 3-[4-(Pyrrolidin-1-ylmethyl)phenyl]piperidine dihydrochloride |
1211572-20-1 |
C16H24N2.2HCL |
More |
| 3-[4-(Pyrrolidin-1-ylmethyl)phenyl]piperidine |
669002-72-6 |
C16H24N2 |
More |
| N-methyl-n-{4-[1-(pyrrolidin-1-yl)ethyl]benzyl}acetamide trifluoroacet |
1211571-97-9 |
C16H24N2O.C2HF3O2 |
More |
| Tert-butyl methyl{2-[4-(1-methyl-4,5-dihydro-1h-imidazol-2-yl)phenyl]e |
1211572-30-3 |
C18H27N3O2 |
More |
| [(3-Chloro-phenylcarbamoyl)-methyl]-carbamic acid tert-butyl ester |
1229247-76-0 |
C13H17ClN2O3 |
More |
| (4-Bromo-benzyl)-(5-methyl-2-nitro-phenyl)-amine |
1229247-80-6 |
C14H13BrN2O2 |
More |
| Methyl 6-(1-hydroxy-1-methylethyl)pyridine-3-carboxylate |
1238877-70-7 |
C10H13NO3 |
More |
| 4-(4,4-Dimethyl-4,5-dihydro-1,3-oxazol-2-yl)benzoic acid |
1238877-66-1 |
C12H13NO3 |
More |
| Methyl 4-[(2-hydroxy-1,1-dimethylethyl)carbamoyl]benzoate |
1238877-64-9 |
C13H17NO4 |
More |
| 1-(Azetidin-3-ylcarbonyl)-4-cyclobutylpiperazine |
1238877-84-3 |
C12H21N3O |
More |
| 1-(Azetidin-3-ylcarbonyl)-4-cyclobutyl-1,4-diazepane |
1238877-60-5 |
C13H23N3O |
More |
| Tert-butyl 4-(azetidin-3-ylcarbonyl)-1,4-diazepane-1-carboxylate |
1238877-79-6 |
C14H25N3O3 |
More |
| 1-[(1-Acetylazetidin-3-yl)carbonyl]-4-cyclobutyl-1,4-diazepane |
1238877-32-1 |
C15H25N3O2 |
More |
| 1-Cyclobutyl-4-[(1-propanoylazetidin-3-yl)carbonyl]-1,4-diazepane |
1238877-33-2 |
C16H27N3O2 |
More |
| Benzyl 3-[(4-cyclobutylpiperazin-1-yl)carbonyl]azetidine-1-carboxylate |
1238877-83-2 |
C20H27N3O3 |
More |
| Benzyl 3-[(4-cyclobutyl-1,4-diazepan-1-yl)carbonyl]azetidine-1-carboxy |
1238876-21-5 |
C21H29N3O3 |
More |
| Tert-butyl 4-({1-[(benzyloxy)carbonyl]azetidin-3-yl}carbonyl)-1,4- dia |
1238877-77-4 |
C22H31N3O5 |
More |
| Methyl 5-({3-[(4-cyclobutyl-1,4-diazepan-1-yl)carbonyl]azetidin-1-yl}c |
1238876-29-3 |
C21H28N4O4 |
More |
| N-(6-cyano-pyridin-3-yl)-benzenesulfonamide |
1255716-67-6 |
C12H9N3O2S |
More |
